Nature Awards MDx Impact Grants

The MDx Impact Grants aim to unlock the potential of PCR to democratise access to accurate diagnostic tests that improve patient outcomes.

We invite research groups to work with us and our partner Seegene to develop tests that address unmet clinical needs. The programme provides researchers with access to Seegene’s syndromic PCR technology and development grants of up to 600,000 USD to perform clinical studies. 

Research groups are permitted to submit up to three project applications per funding cycle. We welcome applications from eligible research groups from around the world.  

Scope of the 2024 MDx Impact Grants: Human infectious diseases

This year, the MDx Impact Grants focus on diagnostic tests for human infectious diseases. Applicants are required to identify suitable pathogen targets, including, if clinically relevant, any variants or subtypes, and perform clinical studies for syndromic PCR diagnostic tests of human infectious diseases.

As Submittable is the primary communication channel used in the management of Nature Awards grants processes, please ensure that your email security settings are configured to allow receipt of emails sent from the Submittable server and/or Submittable is 'whitelisted'. 

You are advised to prepare your application in a standalone document first before copying the elements into this form and to retain this document and share it with your institution's signing officer. 

Please note that you are also expected to warrant that you have shared the MDx Impact Grant’s pro forma service agreement with your institution's funding office and received in principle approval, that requires no more than minor changes. 

Links

To view the website homepage, please visit: www.nature.com/immersive/mdximpactgrants

The full Terms and Conditions of entry: www.nature.com/immersive/mdximpactgrants/terms-and-conditions/index.html 

Further enquiries: mdximpactgrants@springernature.com